Search results
Author(s):
Nicolas M Van Mieghem
Added:
4 weeks ago
NVM Cardiology Conference Reflections: What’s Hot at TCT 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his critical perspective on some of the key late-breaking data highlights from TCT 2025.What should we expect from the new data? Where should we take a closer look at the existing evidence and the premise of these trials? And which results…
View more
Author(s):
Subodh Verma
Added:
2 months ago
ESC Congress 2025 - The SEMA-VR CardioLink-15 trial revealed that semaglutide may enhance endogenous progenitor cell-mediated vasculogenic repair processes.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us to discuss the findings from the SEMA-VR CardioLink-15 trial. The study compared usual care with semaglutide, GLP-1RA for six months in 46 patients with either type 2 diabetes…
View more
TCT 2025 Late-Breaking Science Collection
Video Series
Stavros Stavrakis
Research Area(s) / Expertise:
Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Author
NVM Cardiology Meeting Reflections: TCT 25 Wrap Up
Added:
2 weeks ago
Podcast Episode
Author(s):
Andro Pramana Witarto
,
Bendix Samarta Witarto
,
Shidi Laras Pramudito
,
et al
Added:
1 year ago
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
1 week ago
Giselle Melendez
Research Area(s) / Expertise:
Job title: Assistant Professor
Author
Author(s):
Yimeng Zhang
,
Nimai Desai
,
Derek Connolly
Added:
8 months ago
Cardiovascular Risk in NAFLD
Author(s):
Paula Luque-Linero
,
Jose M Guerra
Added:
1 year ago
Article